Investors & Media

May 17, 2022 International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022

Mar 30, 2022 International Stem Cell Corporation Announces 2021 Fourth Quarter and Year-End Results

Jun 30, 2021 International Stem Cell Corporation Announces Successful Completion of Its Phase 1 Clinical Trial in Parkinson's Disease

Nov 15, 2019 International Stem Cell Corporation Announces Financial Results for the Three and Nine-Months ended September 30, 2019

May 17, 2019 International Stem Cell Corporation Announces Operating Results for the Quarter Ended March 31, 2019

May 08, 2019 International Stem Cell Corporation is Valued at $43 Million Market Value by Edison Investment Research

Apr 29, 2019 International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial

Apr 15, 2019 International Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End Results

Mar 04, 2019 International Stem Cell Corporation Commences Trading on the OTCQX Best Market

Feb 13, 2019 International Stem Cell Corporation Publishes Successful Results in Traumatic Brain Injury

<< < > >>